Details for New Drug Application (NDA): 208390
✉ Email this page to a colleague
The generic ingredient in TICAGRELOR is ticagrelor. There are twenty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ticagrelor profile page.
Summary for 208390
Tradename: | TICAGRELOR |
Applicant: | Watson Labs Inc |
Ingredient: | ticagrelor |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 60MG | ||||
Approval Date: | Sep 4, 2018 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 90MG | ||||
Approval Date: | Sep 4, 2018 | TE: | RLD: | No |
Complete Access Available with Subscription